2024-01-23
基因疗法研发商
医药研发/制造
化学&生物药
KIMCO;
KIMCO;
Dong-A ST;
Dong-A ST;
K2 Investment Partners;
Terra VC;
LoftyRock Investment;
Pathway Partners;
ACVC;
Mirae Asset Venture Investments;
KDB Silicon Valley;
Timefolio Asset Management;
IMM Investment;
KB Investment;
Dayli Partners;
Woori Venture Partners;
Korea Investment Partners;
Sequoia Capital;
Eli Lilly
2021-09-23
基因疗法研发商
医药研发/制造
化学&生物药
Sequoia Capital;
Sequoia Capital;
Company K Partners;
Company K Partners;
DCVC Bio;
Timefolio Asset Management;
SK Holdings;
IMM Investment;
KTB Network;
KB Investment;
Bow Capital;
Dayli Partners;
Eli Lilly;
Korea Investment Partners
2021-09-23
基因疗法研发商
医药研发/制造
化学&生物药
Sequoia Capital;
Sequoia Capital;
Bow Capital;
Bow Capital;
SK Holdings;
DCVC Bio;
Timefolio Asset Management;
IMM Investment;
KB Investment;
Dayli Partners;
Korea Investment Partners;
Company K Partners;
KTB Network;
Eli Lilly
2020-11-19
自动化空间组学解决方案提供商
医疗器械
成像器械
Timefolio Asset Management;
Timefolio Asset Management;
Lifecore Partners;
Lifecore Partners;
Ray;
Illumina Ventures;
LabGenomics;
Xolon Invest;
Ncore Ventures;
CTK Investments
2020-10-12
新药研发商
医药研发/制造
化学&生物药
2020-09-28
治疗性外泌体研发商
医药研发/制造
化学&生物药
Daishin Securities;
Daishin Securities;
Timefolio Asset Management;
Timefolio Asset Management;
Asset One;
Devsisters Ventures;
Kiwoom Securities;
HB Investment;
Daedeok Venture Partners;
Hanyang Securities
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
